Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

Trial Identifier:	D7960C00010
Sponsor:	AstraZeneca
NCTID::	NCT06576765
Start Date:	August 2024
Primary Completion Date:	November 2024
Study Completion Date:	November 2024
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, FL	Hialeah, FL, US, 33014
US, FL	Orlando, FL, US, 32809
US, TX	San Antonio, TX, US, 78215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.